Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation

被引：10
作者：
Klener, Pavel [1 ,2 ]
Salek, David [3 ]
Pytlik, Robert [1 ]
Mocikova, Heidi [4 ,5 ]
Forsterova, Kristina [1 ]
Blahovcova, Petra [1 ]
Campr, Vit [6 ]
Prochazka, Vit [7 ,8 ]
Obr, Ales [7 ,8 ]
Jaksa, Radek [9 ]
Kuntscherova, Jana [10 ]
Boudova, Ludmila [10 ]
Kodet, Roman [6 ]
Janikova, Andrea [3 ]
Trneny, Marek [1 ]
机构：
[1] Charles Univ Prague, Gen Hosp, Med Dept 1, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic
[3] Masaryk Univ Hosp, Dept Hematol & Oncol, Brno, Czech Republic
[4] Charles Univ Prague, Fac Hosp Kralovske Vinohrady, Dept Internal Med & Haematol, Prague, Czech Republic
[5] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[6] Charles Univ Hosp, Fac Med 2, Dept Pathol & Mol Med, Motol, Czech Republic
[7] Palacky Univ, Fac Med & Dent, Dept Hematooncol, Olomouc, Czech Republic
[8] Univ Hosp Olomouc, Olomouc, Czech Republic
[9] Charles Univ Prague, Gen Hosp, Inst Pathol, Prague, Czech Republic
[10] Charles Univ Prague, Med Fac Plzen, Dept Pathol, Prague, Czech Republic
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 02期
关键词：
FOLLOW-UP; IMMUNOCHEMOTHERAPY;
D O I：
10.1002/ajh.25362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E50 / E53
页数：4
相关论文
共 6 条
  • [1] Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
    Chihara, Dai
    Cheah, Chan Y.
    Westin, Jason R.
    Fayad, Luis E.
    Rodriguez, Maria A.
    Hagemeister, Fredrick B.
    Pro, Barbara
    McLaughlin, Peter
    Younes, Anas
    Samaniego, Felipe
    Goy, Andre
    Cabanillas, Fernando
    Kantarjian, Hagop
    Kwak, Larry W.
    Wang, Michael L.
    Romaguera, Jorge E.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (01) : 80 - 88
  • [2] Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue:: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
    Geisler, Christian H.
    Kolstad, Arne
    Laurell, Anna
    Andersen, Niels S.
    Pedersen, Lone B.
    Jerkeman, Mats
    Eriksson, Mikael
    Nordstrom, Marie
    Kimby, Eva
    Boesen, Anne Marie
    Kuittinen, Outi
    Lauritzsen, Grete F.
    Nilsson-Ehle, Herman
    Ralfkiaer, Elisabeth
    Akerman, Mans
    Ehinger, Mats
    Sundstrom, Christer
    Langholm, Ruth
    Delabie, Jan
    Karjalainen-Lindsberg, Marja-Liisa
    Brown, Peter
    Elonen, Erkki
    [J]. BLOOD, 2008, 112 (07) : 2687 - 2693
  • [3] Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur
    Geisler, Christian H.
    Kolstad, Arne
    Laurell, Anna
    Jerkeman, Mats
    Raty, Riikka
    Andersen, Niels S.
    Pedersen, Lone B.
    Eriksson, Mikael
    Nordstrom, Marie
    Kimby, Eva
    Bentzen, Hans
    Kuittinen, Outi
    Lauritzsen, Grete F.
    Nilsson-Ehle, Herman
    Ralfkiaer, Elisabeth
    Ehinger, Mats
    Sundstrom, Christer
    Delabie, Jan
    Karjalainen-Lindsberg, Marja-Liisa
    Brown, Peter
    Elonen, Erkki
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (03) : 355 - 362
  • [4] Treatment of Older Patients with Mantle-Cell Lymphoma
    Kluin-Nelemans, H. C.
    Hoster, E.
    Hermine, O.
    Walewski, J.
    Trneny, M.
    Geisler, C. H.
    Stilgenbauer, S.
    Thieblemont, C.
    Vehling-Kaiser, U.
    Doorduijn, J. K.
    Coiffier, B.
    Forstpointner, R.
    Tilly, H.
    Kanz, L.
    Feugier, P.
    Szymczyk, M.
    Hallek, M.
    Kremers, S.
    Lepeu, G.
    Sanhes, L.
    Zijlstra, J. M.
    Bouabdallah, R.
    Lugtenburg, P. J.
    Macro, M.
    Pfreundschuh, M.
    Prochazka, V.
    Di Raimondo, F.
    Ribrag, V.
    Uppenkamp, M.
    Andre, M.
    Klapper, W.
    Hiddemann, W.
    Unterhalt, M.
    Dreyling, M. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06) : 520 - 531
  • [5] Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
    Le Gouill, S.
    Thieblemont, C.
    Oberic, L.
    Moreau, A.
    Bouabdallah, K.
    Dartigeas, C.
    Damaj, G.
    Gastinne, T.
    Ribrag, V.
    Feugier, P.
    Casasnovas, O.
    Zerazhi, H.
    Haioun, C.
    Maisonneuve, H.
    Houot, R.
    Jardin, F.
    Van den Neste, E.
    Tournilhac, O.
    Le Du, K.
    Morschhauser, F.
    Cartron, G.
    Fornecker, L. -M.
    Canioni, D.
    Callanan, M.
    Bene, M. C.
    Salles, G.
    Tilly, H.
    Lamy, T.
    Gressin, R.
    Hermine, O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) : 1250 - 1260
  • [6] High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine
    Romaguera, JE
    Fayad, L
    Rodriguez, MA
    Broglio, KR
    Hagemeister, FB
    Pro, B
    McLaughlin, P
    Younes, A
    Samaniego, F
    Goy, A
    Sarris, AH
    Dang, NH
    Wang, M
    Beasley, V
    Medeiros, LJ
    Katz, RL
    Gagneja, H
    Samuels, BI
    Smith, TL
    Cabanillas, FF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7013 - 7023
1